News & Updates
Filter by Specialty:

Phase IIb study supports lorundrostat for treatment-resistant hypertension
04 Jun 2025
byAudrey Abella
The phase IIb Advance-HTN trial shows the blood pressure (BP)-lowering effect of lorundrostat in patients with uncontrolled and treatment-resistant hypertension (HTN).